Residue depletion profiles and withdrawal intervals of florfenicol and its metabolite florfenicol amine in plasma and milk of lactating goats after repeated subcutaneous administrations

被引:2
作者
Chen, Qiran [1 ,2 ]
Lin, Zhoumeng [1 ,2 ]
Davis, Jennifer L. [3 ]
Toney, Emily [4 ]
Clapham, Maaike O. [4 ]
Wu, Xue [1 ,2 ]
Tell, Lisa A. [4 ]
机构
[1] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32608 USA
[2] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL 32610 USA
[3] Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA
[4] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA
基金
美国农业部;
关键词
Florfenicol; Florfenicol amine; Goat; Milk; Pharmacokinetics; Withdrawal interval; DISPOSITION KINETICS; DAIRY-COWS; PHARMACOKINETICS; INTRAMAMMARY; SHEEP;
D O I
10.1016/j.yrtph.2024.105707
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Florfenicol is a broad-spectrum and bacteriostatic antibiotic with a time-dependent killing action. It is commonly used to treat respiratory diseases in goats in an extra-label manner. This study aimed to determine the plasma pharmacokinetics and milk residue depletion profiles and calculate the milk withdrawal interval (WDI) of florfenicol and its main metabolite florfenicol amine in lactating goats. Five healthy lactating goats were administered with 40 mg/kg florfenicol by subcutaneous injection, twice, 96 h apart. Plasma and milk samples were collected up to 864 h post the first injection. Non-compartmental analysis was used to estimate the plasma pharmacokinetic parameters. Milk WDIs were calculated using the U.S. Food and Drug Administration (FDA) method and European Medicines Agency (EMA) method. A Monte Carlo simulation was performed to generate simulated data for five virtual animals to meet the data requirement of the FDA method. The calculated milk WDIs based on florfenicol, florfenicol amine, and the combined (the sum of florfenicol and florfenicol amine) were 720.28, 690.45, and 872.69 h after the last injection using the FDA method. In conclusion, this study improves our understanding on the plasma pharmacokinetics and milk residue depletion kinetics of florfenicol and florfenicol amine in lactating ruminants after subcutaneous injections.
引用
收藏
页数:9
相关论文
共 50 条
[1]  
ADAMS PE, 1987, AM J VET RES, V48, P1725
[2]   Comparative plasma pharmacokinetics and tolerance of florfenicol following intramuscular and intravenous administration to camels, sheep and goats [J].
Ali, BH ;
Al-Qarawi, AA ;
Hashaad, M .
VETERINARY RESEARCH COMMUNICATIONS, 2003, 27 (06) :475-483
[3]   Qualitative and Quantitative Drug residue analyses: Florfenicol in white-tailed deer (Odocoileus virginianus) and supermarket meat by liquid chromatography tandem-mass spectrometry [J].
Anderson, Shanoy C. ;
Subbiah, Seenivasan ;
Gentles, Angella ;
Austin, Galen ;
Stonum, Paul ;
Brooks, Tiffanie A. ;
Brooks, Chance ;
Smith, Ernest E. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2016, 1033 :73-79
[4]  
[Anonymous], 2001, Guidance for industry: bioanalytical method validation, P1
[5]  
[Anonymous], 2014, R LANG ENV STAT COMP, V2014
[6]  
[Anonymous], 2018, Bioanalytical method validation guidance for industry
[7]   Effect of three anthelmentics on disposition kinetics of florfenicol in goats [J].
Atef, M. ;
El-Gendi, A. Y. I. ;
Amer, Aziza M. ;
Abd El-Aty, A. M. .
FOOD AND CHEMICAL TOXICOLOGY, 2010, 48 (12) :3340-3344
[8]   Disposition kinetics of florfenicol in goats by using two analytical methods [J].
Atef, M ;
El-Gendi, AY ;
Amer, AMM ;
Abd El-Aty, AM .
JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE, 2001, 48 (03) :129-136
[9]  
Balcomb CC, 2018, AM J VET RES, V79, P107, DOI 10.2460/ajvr.79.1.107
[10]   FLORFENICOL IN NONLACTATING DAIRY-COWS - PHARMACOKINETICS, BINDING TO PLASMA-PROTEINS, AND EFFECTS ON PHAGOCYTOSIS BY BLOOD NEUTROPHILS [J].
BRETZLAFF, KN ;
NEFFDAVIS, CA ;
OTT, RS ;
KORITZ, GD ;
GUSTAFSSON, BK ;
DAVIS, LE .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1987, 10 (03) :233-240